EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

S100A8 as a potential therapeutic target for cancer metastasis

Atsuko Deguchi iD, Yoshiro Maru

Cancer Science · 2025

DOI: 10.1111/cas.16407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2025. Verfasst von Atsuko Deguchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Calgranulin A, Neoplasm Metastasis, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis is a major cause of cancer‐related deaths. Similar to the tumor microenvironment formation, the premetastatic niche develops in distant organs before the arrival of tumor cells. Elucidating the mechanism(s) underlying premetastatic niche formation could contribute to the establishment of effective therapeutic targets for metastasis. Our research indicates that primary tumors hijack Toll‐like receptor 4 (TLR4) signaling to establish a premetastatic niche in the lungs by utilizing an endogenous ligand S100A8. S100A8 is expressed not only in immune cells but also in various types of tumor cells. By focusing on S100A8 as a therapeutic target, we identified at least three multivalent S100A8 inhibitory peptides. Here, we review the tumor‐promoting role of S100A8‐mediated TLR4 signaling and propose S100A8 as a potential therapeutic target for aggressive cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calgranulin ANeoplasm MetastasisNeoplasmsHumansTumor MicroenvironmentSignal TransductionToll-Like Receptor 4AnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

S100A8Toll‐like receptor 4metastasispeptidetumor microenvironment

Substanzen

Calgranulin AToll-Like Receptor 4S100A8 protein, humanTLR4 protein, human

Autor:innen und Institutionen

  • Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Pharmacology, Tokyo Women's Medical University, Tokyo, Japan.
  • Future Robotics Organization, Waseda University, Tokyo, Japan.

ORCID-Profile: Atsuko Deguchi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Deguchi, A., & Maru, Y. (2025). S100A8 as a potential therapeutic target for cancer metastasis. Cancer Science. https://doi.org/10.1111/cas.16407

Vancouver

Deguchi A, Maru Y. S100A8 as a potential therapeutic target for cancer metastasis. Cancer Science. 2025. doi:10.1111/cas.16407

BibTeX
@article{Deguchi2025,
  author = {Deguchi, Atsuko and Maru, Yoshiro},
  title = {S100A8 as a potential therapeutic target for cancer metastasis},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.16407}
}
Kostenlos starten →